APGE Dividend History & Analysis | N/A Yield
APGE has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 20.9% | 0.31% |
| GILD | 155,333 M | 3.14% | 7.99% |
| ABBV | 410,546 M | 2.86% | 7.80% |
| AMGN | 180,930 M | 2.83% | 4.98% |
| HLN | 44,016 M | 1.83% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 7,645 M | 127% | 60.7% |
| HLN | 44,016 M | 51.0% | 100% |
| AMGN | 180,930 M | 8.90% | 100% |
| ABBV | 410,546 M | 7.06% | 100% |
| GILD | 155,333 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare APGE Dividends with its Peer-Group
2.86% Yield
2.83% Yield
3.14% Yield
1.83% Yield
APGE Dividend History: as of November 2025
No dividends paid yet.APGE Dividend FAQ
Apogee Therapeutics, Inc. (NASDAQ: APGE) is a clinical-stage biotechnology firm founded in 2022 and based in Waltham, Massachusetts. Its pipeline targets Type 2 inflammatory diseases, including atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), and chronic obstructive pulmonary disease (COPD). The lead candidate, APG777, is a subcutaneous, extended-half-life monoclonal antibody currently in Phase 2 for AD and Phase 1 for asthma/EoE. Additional assets include APG279 (pre-clinical AD), APG990 (SQ mAb for AD), APG333 (anti-TSLP for asthma/COPD), and APG808 (IL-4Ra targeting mAb for broader Type 2 allergies).
What is the Dividend Yield of APGE?
As of November 2025, APGE`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 63.37.Does APGE pay a dividend?
As of November 2025 APGE does not pay a dividend.How often does APGE pay dividends?
Over the last 12 months, APGE has issued dividend payments.Will APGE pay dividends in 2025?
The next Ex-Dividend date for Apogee Therapeutics (APGE) is currently unknown.What is the next Ex-Dividend Date for APGE?
The next Ex-Dividend date for Apogee Therapeutics (APGE) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of APGE?
APGE's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of APGE?
APGE's 5-Year Yield on Cost is -%. If you bought APGE's shares at 17.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of APGE?
APGE Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does APGE have a good Dividend Yield?
APGE`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of APGE?
The Dividend Payout Ratio of APGE is unknown.What is the Dividend Rating of APGE?
APGE`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-11-11 10:34